| Literature DB >> 28773099 |
Anika Jonitz-Heincke1, Jenny Tillmann2, Annett Klinder3, Simone Krueger4, Jan Philippe Kretzer5, Paul Johan Høl6,7, Alexander C Paulus8, Rainer Bader9.
Abstract
Osteolysis in the periprosthetic tissue can be caused by metallic wear particles and ions that can originate from implant surface corrosion. These products influence cellular behavior and stimulate the expression of proinflammatory cytokines. The purpose of this study was to evaluate the impact of CoCr29Mo6 ions on cell survival, differentiation, and cytokine expression in human osteoblasts and peripheral blood mononuclear cells (PBMCs). Thus, we exposed cells with a mixture of 200 µg/L ion solution and determined cell viability and apoptosis/necrosis. Gene expression analyses of osteoblastic and osteoclastic differentiation markers as well as pro-osteolytic mediators (IL-6, IL-8, TNF-α, MCP-1, MMP1, TIMP1) were performed. These markers were also investigated in mixed cultures of adherent and non-adherent PBMCs as well as in co-cultures of human osteoblasts and PBMCs. The ion solution induced necrosis in osteoblasts and PBMCs in single cultures. All examined mediators were highly expressed in the co-culture of osteoblasts and PBMCs whereas in the single cell cultures only IL-6, IL-8, and MMP1 were found to be stimulated. While the applied concentration of the CoCr29Mo6 ion solutions had only marginal effects on human osteoblasts and PBMCs alone, the co-culture may provide a comprehensive model to study osteolytic processes in response to Co and Cr ions.Entities:
Keywords: CoCr; PBMCs; corrosion; cytokines; inflammation; metal ions; osteoblasts; osteolysis
Year: 2017 PMID: 28773099 PMCID: PMC5551777 DOI: 10.3390/ma10070734
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Analysis of cell viability of human osteoblasts and peripheral blood mononuclear cells (PBMCs) after exposure with 200 µg/L CoCr29Mo6 ion solution. Cells were transferred into standard culture plates allowing adherence over 24 h (osteoblasts) or 72 h (PBMCs). Afterwards, the cell culture medium was replaced by the ion solution. After 48 h and 96 h, metabolic activity was determined by the water soluble tetrazolium salt (WST-1) assay (A,B); Cell proliferation was quantified by DNA measurements (C,D) and live-dead stainings were carried out (E,F). Data are shown as box plots (n = 4). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, treated vs. untreated).
Figure 2Analysis of apoptosis and necrosis of human osteoblasts and PBMCs after exposure with 200 µg/L CoCr29Mo6 ion solution. Cells were transferred into standard culture plates allowing adherence over 24 h (osteoblasts) or 72 h (PBMCs). Afterwards, the cell culture medium was replaced by the ion solution. After 48 h and 96 h, necrosis was determined within cell culture supernatants. For apoptosis, cells were lysed for 30 min at room temperature. Absorbance was measured at 405 nm (reference wave length: 490 nm) and the apoptosis and necrosis rates were then normalised to the untreated control at each time point. Data are shown as box plots (n = 4). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, ** p < 0.01, treated vs. untreated).
Expression of differentiation markers in human osteoblasts and adherent PBMCs after exposure with 200 µg/L CoCr29Mo6 ion solution. Cells were transferred into standard culture plates allowing adherence over 24 h (osteoblasts) or 72 h (PBMCs). Afterwards, the cell culture medium was replaced by the ion solution. After 48 h and 96 h, RNA was isolated and reverse transcribed. For protein measurements (C1CP), supernatants of osteoblasts were used. Gene expression analysis was done by quantitative Realtime PCR (qRT-PCR). Data are shown as median and minimum/maximum values (n ≥ 4; all in %). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, ** p < 0.01, treated vs. untreated; p ≤ 0.05, 48 h vs. 96 h).
| Differentiation Marker | Osteoblasts | Adherent PBMCs | ||
|---|---|---|---|---|
| 48 h | 96 h | 48 h | 96 h | |
Figure 3Influence of CoCr29Mo6 ions in the mixed culture of adherent and non-adherent PBMCs. (A) Light microscopy of PBMCs (bar: 20 µm); (B) Metabolic activity of PBMCs; (C) Gene expression analysis of pro-osteolytic mediators in cultures of adherent/non-adherent PBMCs. Cells were transferred in standard cell culture plates exposing them with 200 µg/L CoCr29Mo6 ions. After 48 h and 96 h, analyses of cell culture experiments were done; (B) Data are shown as box plots (n = 4). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, adherent vs. non-adherent PBMCs); (C) Data are shown as median and minimum/maximum values (n = 4; all in %). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, treated vs. untreated).
Gene expression analyses of pro-osteolytic mediators in human osteoblasts and PBMCs after exposure with 200 µg/L CoCr29Mo6 ion solution. Cells were transferred into standard cell culture plates allowing adherence over 24 h (osteoblasts) or 72 h (PBMCs). Afterwards, the cell culture medium was replaced by the ion solution. After 48 h and 96 h, RNA was isolated and reverse transcribed. Gene expression analyses were done by qRT-PCR. Data are shown as median and minimum/maximum values (n = 4; all in %). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, ** p < 0.01, treated vs. untreated).
| Pro-Osteolytic Mediators | Osteoblasts | Adherent PBMCs | ||
|---|---|---|---|---|
| 48 h | 96 h | 48 h | 96 h | |
Figure 4Light microscopy images of adherent PBMCs (scale bar: 20 µm).
Evaluation of the effects of CoCr29Mo6 ions on co-cultures of PBMCs and osteoblasts in comparison to single-cultured cells (PBMCs: n = 4; PBMCs; osteoblasts: n = 1 (same osteoblastic donor for all PBMC cultures)). PBMCs were transferred into standard culture plates allowing adherence over 72 h. Osteoblasts were seeded into cell culture inserts. After 24 h, cell culture inserts were transferred into the PBMC cultures and the respective cell culture medium was replaced by the ion solution. After 48 h and 96 h, RNA was isolated and reverse transcribed. Gene expression analyses of the differentiation markers and cytokines in the osteoblasts and PBMCs were done by qRT-PCR. Data are shown as median and minimum/maximum values (all in %). Significances between groups were calculated with the Mann-Whitney-U-Test (* p ≤ 0.05, treated vs. untreated).
| Differentiaton or Pro-Osteolytic Mediators | Osteoblasts | Adherent PBMCs |
|---|---|---|
cDNA target sequences for qRT PCR.
| Primer | Forward (Sequence 5′-3′) | Reverse (Sequence 5′-3′) |
|---|---|---|
| Alkaline phosphatase ( | cattgtgaccaccacgagag | ccatgatcacgtcaatgtcc |
| Collagen 1 ( | acgaagacatcccaccaatc | agatcacgtcatcgcacaac |
| Hypoxanthine-guanine phosphoribosyltransferase (HPRT) | ccctggcgtcgtgattagtg | tcgagcaagacgttcagtcc |
| Interleukin 6 ( | tggattcaatgaggagacttgcc | ctggcatttgtggttgggtc |
| Interleukin 8 ( | tctgtgtgaaggtgcagttttg | atttctgtgttggcgcagtg |
| Matrix metalloproteinase 1 ( | agagcagatgtggacatgc | tcccgatgatctcccctgac |
| Monocyte chemotactic protein 1 ( | ccgagaggctgagactaacc | ggcattgattgcatctggctg |
| Osteocalcin ( | ggtgcagcctttgtgtcc | tcagccaactcgtcacagtc |
| Osteoprotegerin ( | tggattcaatgaggagacttgcc | ctggcatttgtggttgggtc |
| Receptor activator of nuclear κ-b ( | agaaaaccaccaaatgaacccc | gccacaagcctcattgatcc |
| Receptor activator of nuclear κ-b-Ligand ( | agaagccaccaaagaattgcag | accatcgctttctctgctctg |
| Tartrate-resistant acid phosphatase 5b ( | gggagatctgtgagccagtg | gtccacatgtccatccaggg |
| Tissue inhibitor of metallo-proteinase 1 ( | attgctggaaaactgcaggatg | gtccacaagcaatgagtgcc |
| Tumour necrosis factor α ( | gttgtagcaaaccctcaagctg | gaggtacaggccctctgatg |
Total ion concentrations of the CoCr29Mo6 stock solution as well as in the experimental solution (200 µg/L in total).
| Content in | Co | Cr | Mo | Ni |
|---|---|---|---|---|
| stock solution | 12.0 ± 2.4 mg/L | 3.9 ± 0.6 mg/L | 0.9 ± 0.1 mg/L | 1.3 ± 0.6 mg/L |
| experimental solution | 120 ± 24 µg/L | 39 ± 5.7 µg/L | 8.8 ± 1.1 µg/L | 12.8 ± 6.0 µg/L |